targeted drug combo shows promise against melanoma
the combination of two experimental pills developed by glaxosmithkline plc has shown promise as a treatment for melanoma, the most deadly type of skin cancer, according to new research.
http://feeds.reuters.com/~r/reuters/healthnews/~3/4f-t_fn0kk4/us-cancer-skin-glaxo-idustre7532c520110604
18760
04 Jun 2011 22:36:57
reuters
health